Myocarditis Screening Methods in Athletes After SARS-CoV-2 Infection – a Systematic Review
International Journal of Sports Medicine · 01.12.2023 · 44 (13) · 929-940
DOI: 10.1055/a-2099-6725 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Sports Medicine, erschienen am 01.12.2023. Verfasst von Theresa Hofbauer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Vienna Doctoral School of Pharmaceutical, Nutritional and Sport Science, Vienna, Austria. Hauptthemen laut MEDLINE: Myocarditis, COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
This review aims to elucidate the myocarditis incidence in SARS-CoV-2-positive athletes and to evaluate different screening approaches to derive sports cardiological recommendations after SARS-CoV-2 infection. The overall incidence of athletes (age span 17–35 years, 70% male) with myocarditis after SARS-CoV-2 infection was 1.2%, with a high variation between studies (which contrasts an incidence of 4.2% in 40 studies within the general population). Studies that used conventional screening based on symptoms, electrocardiogram, echocardiography, and cardiac troponin – only followed by cardiac magnetic resonance imaging in case of abnormal findings – reported lower myocarditis incidences (0.5%, 20/3978). On the other hand, advanced screening that included cardiac magnetic resonance imaging within the primary screening reported higher incidences (2.4%, 52/2160). The sensitivity of advanced screening seems to be 4.8 times higher in comparison to conventional screening. However, we recommend prioritization of conventional screening, as the economical load of advanced screening for all athletes is high and the incidence of myocarditis in SARS-CoV-2-positive athletes and the risk of adverse outcomes seems low. Future research will be important to analyze the long-term effects of myocarditis after infection with SARS-CoV-2 in athletes for risk stratification to optimally guide a safe return to sport.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Vienna Doctoral School of Pharmaceutical, Nutritional and Sport Science, Vienna, Austria.
ORCID-Profile: Theresa Hofbauer
Zitieren
APA
Hofbauer, T., Humann, K., Neidenbach, R. C., & Scharhag, J. (2023). Myocarditis Screening Methods in Athletes After SARS-CoV-2 Infection – a Systematic Review. International Journal of Sports Medicine, 44(13), 929-940. https://doi.org/10.1055/a-2099-6725
Vancouver
Hofbauer T, Humann K, Neidenbach RC, Scharhag J. Myocarditis Screening Methods in Athletes After SARS-CoV-2 Infection – a Systematic Review. International Journal of Sports Medicine. 2023;44(13):929-940. doi:10.1055/a-2099-6725
BibTeX
@article{Hofbauer2023,
author = {Hofbauer, Theresa and Humann, Kathrin and Neidenbach, Rhoia Clara and Scharhag, Jürgen},
title = {Myocarditis Screening Methods in Athletes After SARS-CoV-2 Infection – a Systematic Review},
journal = {International Journal of Sports Medicine},
year = {2023},
volume = {44},
number = {13},
pages = {929--940},
doi = {10.1055/a-2099-6725}
}
EUVIMED